Growth Factors in the Treatment of Diabetic Foot Ulcers: New Technologies, Any Promises?
- 1 March 2007
- journal article
- review article
- Published by SAGE Publications in The International Journal of Lower Extremity Wounds
- Vol. 6 (1), 37-53
- https://doi.org/10.1177/1534734606298416
Abstract
Foot ulcers remain a common problem, leading to increased morbidity in patients with diabetes. Despite the progress that has been achieved in revascularization techniques as well as in off-loading to relieve high-pressure areas, diabetic foot wounds remain a clinical challenge. Growth factors are a major technological advance that promised to change the face of wound healing. The most important of growth factors are recombinant human platelet-derived growth factor-BB and granulocyte colony-stimulating factor. The former has been approved by the FDA for the treatment of neuropathic ulcers when there is adequate blood supply. The latter is less demonstrably useful. Advances include methods of delivering growth factors.Keywords
This publication has 138 references indexed in Scilit:
- Topical Vascular Endothelial Growth Factor Accelerates Diabetic Wound Healing through Increased Angiogenesis and by Mobilizing and Recruiting Bone Marrow-Derived CellsThe American Journal of Pathology, 2004
- Innovative Therapies in Wound HealingJournal of Cutaneous Medicine and Surgery, 2003
- Diabetic foot ulcers: old problems—new technologiesNephrology Dialysis Transplantation, 2001
- Becaplermin Gel (PDGF-BB) as Topical Wound TherapyPlastic & Reconstructive Surgery, 2000
- Cutaneous Wound HealingNew England Journal of Medicine, 1999
- THE EFFECT OF RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR (bFGF) IN FIBRIN ADHESIVE VEHICLE ON THE HEALING OF ISCHAEMIC AND NORMAL INCISIONAL SKIN WOUNDSScandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 1998
- Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating FactorNew England Journal of Medicine, 1992
- The Diabetic FootSouthern Medical Journal, 1991
- Impaired Neurogenic Vascular Response in Patients with Diabetes and Neuropathic Foot LesionsNew England Journal of Medicine, 1988
- Enhancement of epidermal regeneration by biosynthetic epidermal growth factor.The Journal of Experimental Medicine, 1986